Recruiting
Cardiovascular disorder+1
RecruitingStudy of Zilebesiran Added to Standard Treatment to Reduce Heart Problems in Adults with High Blood Pressure and Heart Disease Risk
Investigational
Study of Zilebesiran Added to Standard Treatment to Reduce Heart Problems in Adults with High Blood Pressure and Heart Disease Risk
Investigational
- Disease:Cardiovascular disorderHypertension
- Substances:Zilebesiran
Countries:
The Netherlands
The Netherlands- Participants:18–64 years · 65+ years
- Substances:Zilebesiran
- Sponsor:Alnylam Pharmaceuticals Inc.



